370880-12-9

Basic information

• Product Name: (3aS,6aS)-1-[(1R)-1-phenylethyl]-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-b]pyrrole
• Synonyms: (3aS,6aS)-1-[(1R)-1-phenylethyl]-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-b]pyrrole
• CAS NO: 370880-12-9
• Molecular Weight: 216.326
• Mol File: 370880-12-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (3aS,6aS)-1-[(1R)-1-phenylethyl]-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-b]pyrrole(CAS DataBase Reference)
• NIST Chemistry Reference: (3aS,6aS)-1-[(1R)-1-phenylethyl]-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-b]pyrrole(370880-12-9)
• EPA Substance Registry System: (3aS,6aS)-1-[(1R)-1-phenylethyl]-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-b]pyrrole(370880-12-9)

Safety Data

• Hazardous Substances Data: 370880-12-9(Hazardous Substances Data)

Usage

Description

(3aS,6aS)-1-[(1R)-1-phenylethyl]-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-b]pyrrole is a complex organic compound characterized by a unique molecular structure. It is a pyrrolopyrrole derivative with a hexahydro-2H-pyrrolo[3,4-b]pyrrole core and a phenylethyl substituent. This chiral molecule features a stereocenter at the 1-position of the phenylethyl group, indicating its potential for pharmaceutical or biological activity. Further research is recommended to explore its applications and properties.

Uses

Used in Pharmaceutical Industry:
(3aS,6aS)-1-[(1R)-1-phenylethyl]-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-b]pyrrole is used as a potential pharmaceutical agent for its unique molecular structure and chiral properties. Its hexahydro-2H-pyrrolo[3,4-b]pyrrole core and phenylethyl substituent may contribute to its biological activity, making it a candidate for drug development and therapeutic applications.
Used in Research and Development:
In the field of organic chemistry and molecular biology, (3aS,6aS)-1-[(1R)-1-phenylethyl]-3,3a,4,5,6,6a-hexahydro-2H-pyrrolo[3,4-b]pyrrole serves as a subject for research and development. Its complex structure and chirality offer opportunities for studying molecular interactions, mechanisms of action, and potential applications in various biological processes.

Upstream product

• 370880-01-6 (3aS,6aS)-1-[(1R)-1-phenylethyl]-2,3,3a,4,6,6a-hexahydropyrrolo[3,4-b]pyrrole-5-carboxylic acid ethyl ester 
• 128740-03-4 N-allyl-N-(2-oxoethyl)carbamic acid,ethyl ester 
• 78397-15-6 {[(1R)-1-phenylethyl]amino}acetic acid 

Downstream Products

• 370880-07-2 (3aR,6aR)-1-[(1R)-1-phenethyl]-5-(trifluoroacetyl)octahydropyrrolo[3,4-b]pyrrole 
• 1350552-81-6 (R)-3-amino-1-((3aS,6aS)-5-(2-fluoro-2-methylpropionyl)-hexahydropyrrolo[3,4-b]pyrrol-1(2H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one 
• 1350553-84-2 tert-butyl (R)-1-(2,4,5-trifluorophenyl)-4-((3aS,6aS)-hexahydro-5-(2-fluoro-2-methylpropionyl)-pyrrolo[3,4-b]pyrrol-1(2H)-yl)-4-oxybutan-2-ylcarbamate 
• 1350553-81-9 tert-butyl (R)-1-(2,4,5-trifluorophenyl)-4-((3aS,6aS)-hexahydro-5-(aminoformyl)-pyrrolo[3,4-b]pyrrol-1(2H)-yl)-4-oxybutan-2-ylcarbamate 
• 1350553-80-8 tert-butyl (R)-1-(2,4,5-trifluorophenyl)-4-((3aS,6aS)-hexahydro-5-(methylaminoformyl)-pyrrolo[3,4-b]pyrrol-1(2H)-yl)-4-oxybutan-2-ylcarbamate 
• 1350553-79-5 tert-butyl (R)-1-(2,4,5-trifluorophenyl)-4-((3aS,6aS)-hexahydro-5-(chloroformyl)-pyrrolo[3,4-b]pyrrol-1(2H)-yl)-4-oxybutan-2-ylcarbamate 
• 1350553-78-4 tert-butyl (R)-1-(2,4,5-trifluorophenyl)-4-((3aS,6aS)-hexahydro-5-(N,N-dimethylaminoformyl)-pyrrolo[3,4-b]pyrrol-1(2H)-yl)-4-oxybutan-2-ylcarbamate 
• 1350553-77-3 tert-butyl (R)-1-(2,4,5-trifluorophenyl)-4-((3aS,6aS)-hexahydro5-methoxyformylpyrrolo[3,4-b]pyrrol-1(2H)-yl)-4-oxybutan-2-ylcarbamate 
• 1350553-76-2 tert-butyl (R)-1-(2,4,5-trifluorophenyl)-4-((3aS,6aS)-hexahydro-5-methylpyrrolo[3,4-b]pyrrol-1(2H)-yl)-4-oxybutan-2-ylcarbamate 
• 1350553-75-1 tert-butyl (R)-1-(2,4,5-trifluorophenyl)-4-((3aS,6aS)-hexahydropyrrolo[3,4-b]pyrrol-1(2H)-yl)-4-oxybutan-2-ylcarbamate 
• 1350553-74-0 tert butyl (R)-4-((3aS,6aS)-5-(2,2,2-trifluoroacetyl)hexahydropyrrolo[3,4-b]pyrrol-1(2H)-yl)-1-(2,4,5-trifluorophenyl)-4-oxybutan-2-ylcarbamate 
• 1350553-88-6 tert-butyl (R)-1-(2,4,5-trifluorophenyl)-4-((3aS,6aS)-hexahydro-5-(cyclopropylsulfuryl)-pyrrolo[3,4-b]pyrrol-1(2H)-yl)-4-oxybutan-2-ylcarbamate 
• 1350553-87-5 tert-butyl (R)-1-(2,4,5-trifluorophenyl)-4-((3aS,6aS)-hexahydro-5-(acetyl)-pyrrolo[3,4-b]pyrrol-1(2H)-yl)-4-oxybutan-2-ylcarbamate 
• 1350553-85-3 tert-butyl (R)-1-(2,4,5-trifluorophenyl)-4-((3aS,6aS)-hexahydro-5-(cyclopropylformyl)-pyrrolo[3,4-b]pyrrol-1(2H)-yl)-4-oxybutan-2-ylcarbamate 

Relevant articles and documents

Aryl substituted aminotetrahydropyran compound and use thereof

The invention relates to an aryl substituted aminotetrahydropyran compound and use thereof, and further relates to a pharmaceutical composition comprising the compound. The compound or pharmaceuticalcomposition provided by the invention can be used as a dipeptidyl peptidase-IV (DPP-IV) inhibitor.

Diazabicyclic central nervous system active agents

Compounds of formula I pharmaceutical compositions of these compounds, and use of said compositions to control synaptic transmission in mammals.